NCT01387087View on ClinicalTrials.gov

A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP015K

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
Healthy SubjectsPharmacokinetics of ASP015K
Interventions
DRUG

ASP015K

oral

DRUG

Placebo

oral

Trial Locations (2)

33014

Clinical Pharmacology of Miami, Miami

55114

Prism Research, Saint Paul

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY